Clinical Trials Browser

Terminated × Neuroectodermal Tumors, Primitive × antineoplaston AS 2-1 × Clear all

NCT00003515 2017-09-29

Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors

Phase 2 Terminated

Neuroectodermal Tumors, Primitive